Tag: Orchestra BioMed
Orchestra BioMed secures additional capital from funding partners
Orchestra BioMed has secured US$70 million in new capital from Ligand Pharmaceuticals and Medtronic to advance its late-stage partnered cardiology programmes—arterioventricular interval modulation (AVIM)...